AYTU BIOPHARMA, INC Derivative Liability, Noncurrent
AYTU BIOPHARMA, INC (AYTU) had Derivative Liability, Noncurrent of $1.20 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-09-22
- 2026-06-30: Derivative Liability, Noncurrent $1.20M.
- 2026-03-31: Derivative Liability, Noncurrent $2.18M.
- 2025-12-31: Derivative Liability, Noncurrent $27.34M.
- 2025-09-30: Derivative Liability, Noncurrent $20.42M.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.20M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $2.18M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $27.34M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $20.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $26.33M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $4.13M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $6.39M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $9.40M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $12.74M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $8.61M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $12.89M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $12.31M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $6.40M 10-K · filed 2024-09-26 | |
| 2023-03-31 | $1.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.16M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $5.56M 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $1.80M 10-K · filed 2023-10-12 | |
| 2020-06-30 | $11.37K 10-K · filed 2020-10-06 | |
| 2020-03-31 | $11.37K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $11.37K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $11.37K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $13.20K 10-K · filed 2020-10-06 | |
| 2019-03-31 | $28.51K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $25.99K 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $46.63K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $93.98K 10-K · filed 2019-09-26 | |
| 2018-03-31 | $120.15K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.30M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $3.82M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $0.00 10-K · filed 2017-08-31 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $79.84K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $346.60K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $275.99K 10-K · filed 2017-08-31 | |
| 2016-03-31 | $66.20K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $180.97K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $102.80K 10-Q · filed 2015-11-06 | |
| 2015-08-31 | $103.00K 10-K · filed 2017-08-31 | $102.80K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |